Ridker, P. M. et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Lancet 401, 1293–1301 (2023).
Article CAS PubMed Google Scholar
Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119–1131 (2017).
Article CAS PubMed Google Scholar
Fiolet, A. T. L. et al. Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials. Eur. Heart J. 42, 2765–2775 (2021).
Article CAS PubMed Google Scholar
Libby, P. The changing landscape of atherosclerosis. Nature 592, 524–533 (2021).
Article CAS PubMed Google Scholar
Byrne, R. A. et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur. Heart J. Acute Cardiovasc 44, 3720–3826 (2023).
Ridker, P. M. From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection. Circ. Res. 118, 145–156 (2016).
Article CAS PubMed PubMed Central Google Scholar
Saigusa, R., Winkels, H. & Ley, K. T cell subsets and functions in atherosclerosis. Nat. Rev. Cardiol. 17, 387–401 (2020).
Article CAS PubMed PubMed Central Google Scholar
Porsch, F., Mallat, Z. & Binder, C. J. Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies. Cardiovasc. Res. 117, 2544–2562 (2021).
Roy, P., Orecchioni, M. & Ley, K. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. Nat. Rev. Immunol. 22, 251–265 (2022).
Article CAS PubMed Google Scholar
Mallat, Z. & Binder, C. J. The why and how of adaptive immune responses in ischemic cardiovascular disease. Nat. Cardiovasc. Res. 1, 431–444 (2022).
Article PubMed PubMed Central Google Scholar
Conrad, N. et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet 400, 733–743 (2022).
Smolen, J. S. et al. Rheumatoid arthritis. Nat. Rev. Dis. Prim. 4, 18001 (2018).
Kaul, A. et al. Systemic lupus erythematosus. Nat. Rev. Dis. Prim. 2, 16039 (2016).
Skaggs, B. J., Hahn, B. H. & McMahon, M. Accelerated atherosclerosis in patients with SLE – mechanisms and management. Nat. Rev. Rheumatol. 8, 214–223 (2012).
Article CAS PubMed PubMed Central Google Scholar
Ambler, W. G. & Kaplan, M. J. Vascular damage in systemic lupus erythematosus. Nat. Rev. Nephrol. 20, 251–265 (2024).
Article CAS PubMed Google Scholar
Weber, B. N., Giles, J. T. & Liao, K. P. Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease. Nat. Rev. Rheumatol. 19, 417–428 (2023).
Forte, F. et al. Association of systemic lupus erythematosus with peripheral arterial disease: a meta-analysis of literature studies. Rheumatology 59, 3181–3192 (2020).
Restivo, V. et al. Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus. Autoimmun. Rev. 21, 102925 (2022).
Article CAS PubMed Google Scholar
Yafasova, A. et al. Long-term cardiovascular outcomes in systemic lupus erythematosus. J. Am. Coll. Cardiol. 77, 1717–1727 (2021).
Manzi, S. et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am. J. Epidemiol. 145, 408–415 (1997).
Article CAS PubMed Google Scholar
Sparks, J. A. et al. Rheumatoid arthritis and mortality among women during 36 years of prospective follow-up: results from the Nurses’ Health Study. Arthritis Care Res 68, 753–762 (2016).
Bartoloni, E. et al. Cardiovascular disease risk burden in primary Sjögren’s syndrome: results of a population-based multicentre cohort study. J. Intern. Med. 278, 185–192 (2015).
Article CAS PubMed Google Scholar
Butt, S. A. et al. Cardiovascular manifestations of systemic sclerosis: a Danish nationwide cohort study. J. Am. Heart Assoc. 8, e013405 (2019).
Article PubMed PubMed Central Google Scholar
Kiani, A. N. Coronary calcification in SLE: comparison with the Multi-Ethnic Study of Atherosclerosis. Rheumatology 54, 1976–1981 (2015).
Article CAS PubMed PubMed Central Google Scholar
Carlucci, P. M. et al. Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus. JCI Insight 3, e99276 (2018).
Article PubMed PubMed Central Google Scholar
Agca, R. et al. Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis. Rheumatology 60, 3360–3368 (2021).
Article CAS PubMed PubMed Central Google Scholar
Geraldino-Pardilla, L. et al. Arterial inflammation detected with 18F-fluorodeoxyglucose-positron emission tomography in rheumatoid arthritis. Arthritis Rheumatol. 70, 30–39 (2018).
Article CAS PubMed Google Scholar
Hansen, P. R., Feineis, M. & Abdulla, J. Rheumatoid arthritis patients have higher prevalence and burden of asymptomatic coronary artery disease assessed by coronary computed tomography: a systematic literature review and meta-analysis. Eur. J. Intern. Med. 62, 72–79 (2019).
Tyrrell, P. N. et al. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler. Thromb. Vasc. Biol. 30, 1014–1026 (2010).
Article CAS PubMed Google Scholar
Willeit, P. et al. Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: meta-analysis of 119 clinical trials involving 100 667 patients. Circulation 142, 621–642 (2020).
Article CAS PubMed PubMed Central Google Scholar
Gautier, E. L. et al. Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice. Arterioscler. Thromb. Vasc. Biol. 27, 1625–1631 (2007).
Article CAS PubMed Google Scholar
Aprahamian, T. et al. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J. Exp. Med. 199, 1121–1131 (2004).
留言 (0)